T1	Participants 54 94	patients with tuberous sclerosis complex
T2	Participants 235 334	patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex
T3	Participants 1714 1744	117 randomly assigned patients
T4	Participants 2975 3078	patients who have few treatment options and who need continued treatment for tuberous sclerosis complex
